Summary
Jacob Hurst is a CTO and multidisciplinary technology leader with 12 years’ experience applying machine learning to immunology as co-founder of Etcembly, where he leads development of the EMLy™ platform to map T cell repertoires and decode the “Immuniverse.” He combines hands-on computational engineering with domain fluency in biological data to turn large-scale immune sequencing into actionable insights for pandemic response, therapeutics and vaccine design. Based in Oxford, he focuses on bridging experimental scale-ups and production-ready ML tooling, accelerating discovery through lean, deployable systems. Known for recruiting and mentoring polymaths, he pairs technical depth with clear communication to clinicians and researchers, helping translate complex clonotype dynamics into clinical value.
12 years of coding experience